Changes for page Customer segments in Health and Wellbeing Living Labs
Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.5
edited by Sarantis Dimitriadis
on 2022/06/02 10:48
on 2022/06/02 10:48
Change comment:
There is no comment for this version
To version 5.11
edited by Sarantis Dimitriadis
on 2022/06/07 10:26
on 2022/06/07 10:26
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -7,6 +7,8 @@ 7 7 (% class="western" lang="en-GB" style="text-align:justify" %) 8 8 (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following: 9 9 10 +: 11 + 10 10 * ((( 11 11 (% lang="en-US" %)**Non-professional end users:** 12 12 ... ... @@ -15,6 +15,8 @@ 15 15 * (% lang="en-US" %)**Public health and social service clients: **Those who use public services. 16 16 ))) 17 17 20 +: 21 + 18 18 * ((( 19 19 (% lang="en-US" %)**Professional end users** 20 20 ... ... @@ -25,9 +25,13 @@ 25 25 * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level. 26 26 ))) 27 27 32 +: 33 + 28 28 (% class="western" lang="en-GB" %) 29 29 (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows: 30 30 37 +: 38 + 31 31 * ((( 32 32 (% lang="en-US" %)**Private sector organizations: **(business developers and researchers) 33 33 ... ... @@ -42,6 +42,8 @@ 42 42 * (% lang="en-US" %)Pharmaceutical companies 43 43 ))) 44 44 53 +: 54 + 45 45 * ((( 46 46 (% lang="en-GB" %) 47 47 (% lang="en-US" %)**Public sector organizations:** ... ... @@ -57,6 +57,8 @@ 57 57 * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process. 58 58 ))) 59 59 70 +: 71 + 60 60 * ((( 61 61 (% lang="en-GB" %) 62 62 (% lang="en-US" %)**Education and research organizations:** ... ... @@ -70,6 +70,8 @@ 70 70 * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers 71 71 ))) 72 72 85 +: 86 + 73 73 * ((( 74 74 (% lang="en-GB" %) 75 75 (% lang="en-US" %)**Civil society organizations:** ... ... @@ -77,6 +77,8 @@ 77 77 * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level. 78 78 ))) 79 79 94 +: 95 + 80 80 * ((( 81 81 (% lang="en-GB" %) 82 82 (% lang="en-US" %)**Networks and clusters:** ... ... @@ -85,189 +85,189 @@ 85 85 * (% lang="en-US" %)International, national, regional and local networks 86 86 ))) 87 87 104 +: 105 + 88 88 (% class="western" lang="en-GB" %) 89 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .107 +(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table . 90 90 91 -(% cellspacing="0" style="border-collapse:collapse;margin-left:auto; margin-right:auto" %)92 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; padding:0.04in 0in;text-align:center; vertical-align:middle; width:634px" %)(((109 +(% style="margin-left:auto; margin-right:auto" %) 110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)((( 93 93 (% class="western" lang="en-GB" style="text-align:center" %) 94 94 (% lang="en-US" %)**Age or age group** 95 95 ))) 96 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 97 -(% class="western" lang="en-GB" %) 114 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 98 98 (% lang="en-US" %)Specific age range 99 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 100 -(% class="western" %) 116 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 101 101 102 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)(((118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 103 103 (% class="western" %) 104 104 105 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)(((121 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)((( 106 106 (% class="western" %) 107 107 108 108 ))) 109 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 12px;padding:0in;text-align:justify; vertical-align:middle; width:153px" %)(((125 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 110 110 (% class="western" lang="en-GB" %) 111 111 (% lang="en-US" %)Elderly 112 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:justify; vertical-align:middle; width:153px" %)(((128 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 113 113 (% class="western" lang="en-GB" %) 114 114 (% lang="en-US" %)Adults 115 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:justify; vertical-align:middle; width:153px" %)(((131 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 116 116 (% class="western" lang="en-GB" %) 117 117 (% lang="en-US" %)Youth 118 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:justify; vertical-align:middle; width:152px" %)(((134 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 119 119 (% class="western" lang="en-GB" %) 120 120 (% lang="en-US" %)Children 121 121 ))) 122 -|(% colspan="4" style="border- bottom:none; border-left:none; border-right:none; border-top:none; height:12px;padding:0in;vertical-align:top; width:634px" %)(((138 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 123 123 (% class="western" %) 124 124 125 125 ))) 126 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 12px;padding:0.04in 0in;text-align:center; vertical-align:middle; width:634px" %)(((142 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 127 127 (% class="western" lang="en-GB" style="text-align:center" %) 128 128 (% lang="en-US" %)**Health status** 129 129 ))) 130 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 12px;padding:0in;text-align:justify; vertical-align:middle; width:153px" %)(((146 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 131 131 (% class="western" lang="en-GB" %) 132 132 (% lang="en-US" %)Healthy 133 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:justify; vertical-align:middle; width:153px" %)(((149 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 134 134 (% class="western" lang="en-GB" %) 135 135 (% lang="en-US" %)Patient 136 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:justify; vertical-align:middle; width:153px" %)(((152 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 137 137 (% class="western" lang="en-GB" %) 138 138 (% lang="en-US" %)Rehabilitant 139 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:justify; vertical-align:middle; width:152px" %)(((155 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 140 140 (% class="western" lang="en-GB" %) 141 141 (% lang="en-US" %)Recovered/Survivor 142 142 ))) 143 -|(% colspan="4" style="border- bottom:none; border-left:none; border-right:none; border-top:none; height:12px;padding:0in;vertical-align:top; width:634px" %)(((159 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 144 144 (% class="western" %) 145 145 146 146 ))) 147 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 12px;padding:0.04in 0in;text-align:center; vertical-align:middle; width:634px" %)(((163 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 148 148 (% class="western" lang="en-GB" style="text-align:center" %) 149 149 (% lang="en-US" %)**A specific disease, disorder or disability** 150 150 ))) 151 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((167 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 152 152 (% class="western" lang="en-GB" %) 153 153 (% lang="en-US" %)ADHD 154 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((170 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 155 155 (% class="western" lang="en-GB" %) 156 156 (% lang="en-US" %)Dementia 157 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((173 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 158 158 (% class="western" lang="en-GB" %) 159 159 (% lang="en-US" %)Parkinsons’ disease 160 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((176 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 161 161 (% class="western" lang="en-GB" %) 162 162 (% lang="en-US" %)Loneliness and Social Isolation 163 163 ))) 164 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 11px;padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((180 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 165 165 (% class="western" lang="en-GB" %) 166 166 (% lang="en-US" %)Autism 167 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((183 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 168 168 (% class="western" lang="en-GB" %) 169 169 (% lang="en-US" %)Down syndrome 170 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((186 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 171 171 (% class="western" lang="en-GB" %) 172 172 (% lang="en-US" %)Physical disability 173 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((189 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 174 174 (% class="western" lang="en-GB" %) 175 175 (% lang="en-US" %)Mental health 176 176 ))) 177 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((193 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 178 178 (% class="western" lang="en-GB" %) 179 179 (% lang="en-US" %)Cardiovascular disease 180 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((196 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 181 181 (% class="western" lang="en-GB" %) 182 182 (% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF) 183 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((199 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 184 184 (% class="western" lang="en-GB" %) 185 185 (% lang="en-US" %)Sleep apnea/apnea 186 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((202 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 187 187 (% class="western" lang="en-GB" %) 188 188 (% lang="en-US" %)Mild cognitive impairment 189 189 ))) 190 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((206 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 191 191 (% class="western" lang="en-GB" %) 192 192 (% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD) 193 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((209 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 194 194 (% class="western" lang="en-GB" %) 195 195 (% lang="en-US" %)Language disability 196 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((212 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 197 197 (% class="western" lang="en-GB" %) 198 198 (% lang="en-US" %)Substance abuse (drugs, alcohol) 199 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((215 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 200 200 (% class="western" lang="en-GB" %) 201 201 (% lang="en-US" %)Multiple sclerosis 202 202 ))) 203 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 50px;padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((219 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 204 204 (% class="western" lang="en-GB" %) 205 205 (% lang="en-US" %)Cognitive disorder (mild, major) 206 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((222 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 207 207 (% class="western" lang="en-GB" %) 208 208 (% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation 209 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((225 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 210 210 (% class="western" lang="en-GB" %) 211 211 (% lang="en-US" %)Trauma patient 212 212 213 213 (% class="western" lang="en-GB" %) 214 214 (% lang="en-US" %)(e.g., a spinal cord injury) 215 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((231 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 216 216 (% class="western" lang="en-GB" %) 217 217 (% lang="en-US" %)Neurodegenerative diseases 218 218 ))) 219 -|(% colspan="4" style="border- bottom:none; border-left:none; border-right:none; border-top:none; height:12px;padding:0in;vertical-align:top; width:634px" %)(((235 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 220 220 (% class="western" %) 221 221 222 222 ))) 223 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 12px;padding:0.04in 0in;text-align:center; vertical-align:middle; width:634px" %)(((239 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 224 224 (% class="western" lang="en-GB" style="text-align:center" %) 225 225 (% lang="en-US" %)**Clients of a specific service** 226 226 ))) 227 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 11px;padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((243 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 228 228 (% class="western" lang="en-GB" %) 229 229 (% lang="en-US" %)Child welfare 230 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((246 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 231 231 (% class="western" lang="en-GB" %) 232 232 (% lang="en-US" %)Nursing home 233 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((249 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 234 234 (% class="western" lang="en-GB" %) 235 235 (% lang="en-US" %)Employment service 236 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((252 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 237 237 (% class="western" %) 238 238 239 239 ))) 240 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 12px;padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((256 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 241 241 (% class="western" lang="en-GB" %) 242 242 (% lang="en-US" %)Early childhood education 243 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((259 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 244 244 (% class="western" lang="en-GB" %) 245 245 (% lang="en-US" %)Home care 246 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((262 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 247 247 (% class="western" lang="en-GB" %) 248 248 249 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((265 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 250 250 (% class="western" lang="en-GB" %) 251 251 252 252 ))) 253 -|(% colspan="4" style="border- bottom:none; border-left:none; border-right:none; border-top:none; height:12px;padding:0in;vertical-align:top; width:634px" %)(((269 +|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)((( 254 254 (% class="western" %) 255 255 256 256 ))) 257 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 12px;padding:0.04in 0in;text-align:center; vertical-align:middle; width:634px" %)(((273 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)((( 258 258 (% class="western" lang="en-GB" style="text-align:center" %) 259 259 (% lang="en-US" %)**Vulnerable groups** 260 260 ))) 261 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 50px;padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((277 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 262 262 (% class="western" lang="en-GB" %) 263 263 (% lang="en-US" %)Minors/Children 264 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((280 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 265 265 (% class="western" lang="en-GB" %) 266 266 (% lang="en-US" %)Single parents with minor children 267 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((283 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 268 268 (% class="western" lang="en-GB" %) 269 269 (% lang="en-US" %)Persons subjected to psychological, physical or sexual violence 270 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((286 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 271 271 (% class="western" lang="en-GB" %) 272 272 (% lang="en-US" %)Substance users 273 273 ... ... @@ -274,51 +274,51 @@ 274 274 (% class="western" lang="en-GB" %) 275 275 (% lang="en-US" %)(drugs, alcohol) 276 276 ))) 277 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((293 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 278 278 (% class="western" lang="en-GB" %) 279 279 (% lang="en-US" %)Disabled people 280 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((296 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 281 281 (% class="western" lang="en-GB" %) 282 282 (% lang="en-US" %)Victims of trafficking in human beings 283 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((299 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 284 284 (% class="western" lang="en-GB" %) 285 285 (% lang="en-US" %)Ethnic minorities and immigrants 286 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((302 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 287 287 (% class="western" lang="en-GB" %) 288 288 (% lang="en-US" %)Isolated people 289 289 ))) 290 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((306 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 291 291 (% class="western" lang="en-GB" %) 292 292 (% lang="en-US" %)Elderly people 293 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((309 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 294 294 (% class="western" lang="en-GB" %) 295 295 (% lang="en-US" %)Persons with serious illnesses 296 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((312 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 297 297 (% class="western" lang="en-GB" %) 298 298 (% lang="en-US" %)Homeless people 299 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((315 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 300 300 (% class="western" lang="en-GB" %) 301 301 (% lang="en-US" %)Ex-prisoners and people with criminal background 302 302 ))) 303 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((319 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)((( 304 304 (% class="western" lang="en-GB" %) 305 305 (% lang="en-US" %)Pregnant women 306 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((322 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 307 307 (% class="western" lang="en-GB" %) 308 308 (% lang="en-US" %)Persons with mental disorders 309 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:153px" %)(((325 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 310 310 (% class="western" lang="en-GB" %) 311 311 312 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in;text-align:left; vertical-align:middle; width:152px" %)(((328 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 313 313 (% class="western" lang="en-GB" %) 314 314 315 315 ))) 316 316 333 +: 317 317 318 318 (% class="western" lang="en-GB" %) 319 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .336 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) . 320 320 321 - 322 322 |**Researcher expertise**|**Brief use case description** 323 323 |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making 324 324 |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)